ArticleJournal of thoracic disease2018

Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis.

Tomoo KishabaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.